Millennium Management

Millennium Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Millennium Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.5M	Hold	75,000	–	–	﹤0.01%	4112
2025 Q4	$1.73M	Hold	75,000	–	–	﹤0.01%	4070
2025 Q3	$1.28M	Hold	75,000	–	–	﹤0.01%	4417
2025 Q2	$600K	Hold	75,000	–	–	﹤0.01%	4778
2025 Q1	$674K	Hold	75,000	–	–	﹤0.01%	4631
2024 Q4	$1.07M	Hold	75,000	–	–	﹤0.01%	4147
2024 Q3	$525K	Hold	75,000	–	–	﹤0.01%	4795
2024 Q2	$654K	Hold	75,000	–	–	﹤0.01%	4422
2024 Q1	$828K	Hold	75,000	–	–	﹤0.01%	4463
2023 Q4	$235K	Hold	75,000	–	–	﹤0.01%	5096
2023 Q3	$143K	Hold	75,000	–	–	﹤0.01%	5233
2023 Q2	$157K	Hold	75,000	–	–	﹤0.01%	5212
2023 Q1	$138K	Hold	75,000	–	–	﹤0.01%	5312
2022 Q4	$65K	Buy	+75,000	New	+$61.7K	﹤0.01%	5714

Other funds holding NAMSW

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return